Gail Ackermann Selected Research

Gail Ackermann Research Topics

3	Infections 01/2021 - 09/2019
3	COVID-19 01/2021 - 11/2020
2	Lung Diseases (Lung Disease) 06/2020 - 01/2019
2	Cystic Fibrosis (Mucoviscidosis) 06/2020 - 09/2019
2	Dysbiosis 01/2019 - 07/2016
1	Colitis 01/2022
1	Ulcerative Colitis 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2021
1	Substance-Related Disorders (Drug Abuse) 08/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Atherosclerosis 03/2019
1	Hypoxia (Hypoxemia) 03/2019
1	Hypercapnia 03/2019
1	Obstructive Sleep Apnea 03/2019
1	Inflammation (Inflammations) 01/2019
1	Psoriatic Arthritis 01/2014
1	Anterior Uveitis 01/2014
1	Ankylosing Spondylitis 01/2014
1	Reactive Arthritis (Reiter Disease) 01/2014

4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Biological ProductsIBA 08/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Pharmaceutical PreparationsIBA 09/2019
1	Virulence Factors (Pathogenicity Factors)IBA 09/2019
1	Apolipoproteins E (ApoE)IBA 03/2019
1	16S Ribosomal RNAIBA 03/2019
1	Amino Acids FDA Link 01/2019
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2019
1	EnzymesIBA 01/2019
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2014